Agios Pharmaceuticals (AGIO) announced that Jeffrey Capello has been appointed to its board of directors. Agios also announced that Paul Clancy will step down from the board of directors at the end of his term, effective June 13, 2023. Most recently, he was the chief financial officer for Biogen (BIIB), where he partnered with the executive team to achieve consistent and predictable financial outcomes while enhancing the R&D pipeline and implementing a disciplined capital allocation process.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on AGIO:
- Agios Appoints Jeffrey Capello to Board of Directors
- Agios to Webcast Conference Call of First Quarter 2023 Financial Results on May 4, 2023
- Agios Publishes 2023 Environmental, Social and Governance (ESG) Report
- Fly Insider: Southwest Gas, Pathward among week’s notable insider trades
- TipRanks ‘Perfect 10’ List: These 2 Healthcare Stocks Look Compelling at Current Levels
